UBX - Unity Biotechnology, Inc

Healthcare - Sector

UBX is currently covered by 4 analysts with average potential upside of $-20.25 (-26.27%) backed by 3 price targets and 19 ratings. Analyst's average stock valuation to be materialised ratio is 75% with an average time for price targets to be met of 21.25 days.

Most recent stock forecast was given by ANDREAS ARGYRIDES from WEDBUSH on 02-Nov-2022.

Highest price target for UBX is 84, Lowest price target is 2, average price target is 43.

Best performing analysts who are covering UBX - Unity Biotechnology, Inc:

Yigal Nochomovitz Salim Syed Elemer Piros Andreas Argyrides

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

8

$5.29 (195.20%)

3 months 14 days ago

1/1 (100%)

$-5.7 (-41.61%)

2

Buy

8

$5.29 (195.20%)

5

3 months 15 days ago

3/3 (100%)

$-19.23 (-46.85%)

62

Buy

10 months 26 days ago

1/1 (100%)

$-57.3 (-62.08%)

21

Show more analysts

This chart will make you best informed on how analysts see your stock and which of them does well in less than two minutes.

28 days free trial

We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important

For each analyst know for every call if it has been before or after the stock price moved

Understand how each analyst reacts to stock price movement

Get Started or Login